ArticleScientific reports2025
Translation, cross-cultural adaptation, and evaluation of psychometric properties of the cystic fibrosis stigma scale.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Translation, cross-cultural adaptation, and evaluation of psychometric properties of the cystic fibrosis stigma scale.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To translate, cross-culturally adapt, and evaluate the psychometric properties of the Cystic Fibrosis (CF) Stigma Scale. This exploratory methodological study involved the translation and cross-cultural adaptation using the translation, back-translation, review by experts committee, and pre-test steps. The psychometric properties were analyzed by applying the adapted instrument to a sample of 52 Brazilian individuals with CF over 18 years old. Moreover, the participants responded to the Short-Form 12-Item Survey - version 2 (SF-12v2), General Anxiety Disorder 7-item scale (GAD-7) and Cystic Fibrosis Quality of Life Questionnaire - Revised (CFQ-R). The content validity, test-retest reliability, and convergent validity were also assessed. The translation and cross-cultural adaptation obtained Cohen's kappa coefficients > 0.61 in the experts committee step and ranged between 0.48 and 0.72 in the pre-test. The Brazilian version of the CF Stigma Scale showed excellent psychometric properties, observed by the internal consistency (α = 0.836), mean correlation between items (0.3) and test-retest reliability (r = 0.886; p < 0.0001), and convergent validity (positive correlation with the anxiety scale and negative correlation with scores of overall and specific quality of life for CF). The Brazilian version of the CF Stigma Scale was accurately translated and cross-culturally adapted, with favorable psychometric properties for future studies involving the stigma experience in Brazilian individuals with CF over 18 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.